Table 2 Levels of soluble MICA in different cancer patients
|  | Number of cases | Sex (male/female) | Age (years) mean ± SD (range) | sMICA (pg/ml) | P (vs controls) |
|---|---|---|---|---|---|
Liver cancer | 141 | 118/23 | 52.7 ± 11.2(24-75) | 743.4 ± 110.8 | <0.0001 |
Lung cancer | 70 | 54/16 | 59.5 ± 10.5(39-79) | 192.3 ± 258.2 | 0.095 |
Breast cancer | 57 | 0/57 | 50.0 ± 11.5(29-72) | 162.5 ± 116.1 | >0.05 |
Gastric cancer | 77 | 63/14 | 52.4 ± 12.4(20-78) | 264.4 ± 524.8 | 0.075 |
Colorectal cancer | 58 | 39/19 | 58.8 ± 16.3(13-89) | 176.4 ± 147.9 | >0.05 |
Cervical/ovary cancer | 46 | 0/46 | 46.3 ± 8.9(23-70) | 168.3 ± 173.3 | >0.05 |
Nasopharyngeal cancer | 21 | 19/2 | 47.1 ± 10.9(30-74) | 238.2 ± 318.6 | 0.087 |
Lymphoma | 25 | 13/12 | 48.2 ± 13.6(17-70) | 140.9 ± 137.6 | >0.05 |
Controls | 141 | 81/60 | 44.0 ± 11.4(22-70) | 168.5 ± 56.7 |  |